# PDE3B in Metabolic Regulation

> **NCT06533007** · — · ENROLLING_BY_INVITATION · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 40 (estimated)

## Conditions studied

- Type 2 Diabetes
- Cardiometabolic Syndrome
- Cardiovascular Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06533007
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-01
- **Primary completion:** 2028-09
- **Final completion:** 2029-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533007, "PDE3B in Metabolic Regulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06533007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*